This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Antibiotics developer Zavante Therapeutics Inc. raised $45mm through a Series A financing. The company sold $35mm in equity to lead investors Frazier Healthcare Partners and Longitude Capital (each VC adds a board member) as well as Aisling Capital (adds a board observer). Zavante got another $10mm by converting outstanding notes.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?